ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
ANI Pharmaceuticals (Nasdaq: ANIP) announced that CEO Nikhil Lalwani will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 3:45 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ANI Pharmaceuticals (Nasdaq: ANIP) announced that CEO Nikhil Lalwani will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference on Wednesday, June 3, 2026 at 3:45 p.m. ET. A live and archived webcast will be available on the company’s investor relations website for 90 days.
Details
News Market Reaction – ANIP
On May 27, the day this news came out, ANIP closed 0.43% above the previous close.
Data tracked by StockTitan Argus for the May 27 session.
Key Figures
- Conference date
- June 3, 2026
- Jefferies Global Healthcare Conference fireside chat
- Conference time
- 3:45 p.m. ET
- Scheduled start time of fireside chat webcast
- Webcast replay period
- 90 days
- Duration the conference webcast replay will be accessible
Historical Context
-
Strong Q1 2026 growth, higher 2026 guidance, $100M buyback authorization.
-
Scheduled May 8 earnings release and webcast details for Q1 2026.
-
FDA approval and launch of Pimozide Tablets with 180-day CGT exclusivity.
-
Launch of Carbamazepine ER capsules in limited-competition generic market.
-
FDA final approval and launch of Isosorbide Mononitrate generic Monoket.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PRINCETON, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, Chief Executive Officer, will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference as follows:
| Date: | Wednesday, June 3, 2026 |
| Time: | 3:45 p.m. ET |
| Webcast: | Click Here |
The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals.com, under the Investors section under Events and Presentations. The replay of the webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit https://www.anipharmaceuticals.com.
Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E: Irina.koffler@anipharmaceuticals.com
Media Relations:
Argot Partners
T: 212-600-1494
E: ani@argotpartners.com
SOURCE: ANI Pharmaceuticals, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.